Novaptech specializes in the development and application of aptamers, which are short, single-stranded DNA or RNA molecules that can bind specifically to various biological targets, including proteins, small molecules, and cells. The company employs a sophisticated selection process known as SELEX (Systematic Evolution of Ligands by EXponential enrichment) to create custom aptamers tailored for specific applications in diagnostics, therapeutics, and analytical chemistry. This process allows Novaptech to produce aptamers with high specificity and affinity, making them suitable for a wide range of uses, from detecting disease biomarkers to monitoring environmental contaminants. The versatility of aptamers, combined with their stability and ease of modification, positions them as a superior alternative to traditional antibodies in many biotechnological applications.

In addition to custom aptamer development, Novaptech is committed to advancing the field through innovative research and development. The company focuses on optimizing aptamer performance and exploring new methodologies for their application in diagnostics and therapeutics. Their proprietary technology enables the creation of rapid and multiplexed aptamer-based assays, which can significantly enhance the speed and accuracy of biomarker detection. By leveraging their expertise, Novaptech aims to provide tailored solutions that address complex challenges in the pharmaceutical, life sciences, and environmental sectors, ultimately contributing to improved diagnostic and therapeutic outcomes.

France

Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects.
Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies.
Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has more than 26 years of experience in aptamer selection.

Novaptech

Company Details